Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ASCO 2014: Doubling Down on Next-Gen Cancer Drugs
ASCO 2014: Doubling Down on Next-Gen Cancer Drugs
ASCO 2014: Doubling Down on Next-Gen Cancer Drugs
Submitted by
admin
on June 3, 2014 - 12:26pm
Source:
Motley Fool
News Tags:
ASCO
Roche
Amgen
blinatumomab
AstraZeneca
cancer
biospecific antibodies
Headline:
ASCO 2014: Doubling Down on Next-Gen Cancer Drugs
Do Not Allow Advertisers to Use My Personal information
